… receive secondary prevention treatments than patients with obstructive coronary artery disease
(… Cox multivariable analysis, including all secondary prevention drugs, showed that only …

… This paper reviews the current state of knowledge of aspirin dosing in secondary prevention
of CAD and points out the ambiguity in this seemingly well-known topic, highlighting the …

… Clopidogrel offers a small but statistically significant advantage over aspirin for secondary
prevention among all patients with cardiovascular disease. However, data from the …

Objective Peripheral artery disease (PAD) is common worldwide, and PAD patients are
increasingly offered lower limb revascularization procedures. The aim of this population-based …

… In conclusion, LLDs for the secondary prevention of CAD were underused in this at-risk
population. Older patients were at particular risk of undertreatment, but other nonclinical and …

… by the presence of three-vessel coronary disease (n = 304) or recent … secondary prevention
(n = 263) or to a more conventional strategy based on treatment of coronary artery disease …

… life-year saved with pravastatin in secondary prevention of CAD varied from $7,124 to $12,665…
Increasing evidence suggests that secondary prevention of coronary artery disease (CAD) …

… the use of colchicine in secondary prevention of CAD. Of note, the inclusion of LoDoCo (low-dose
colchicine for secondary prevention of cardiovascular disease) 12 trial may introduce …

… This study assessed practice variations in secondary prevention medication prescriptions
among coronary artery disease (CAD) patients treated in outpatient practices participating in …

… This article reviews the highlights of the >25 prospective epidemiologic studies now
published on Lp-PLA 2 as a risk marker in primary or secondary prevention. These trials …